# Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy

> **NCT02305394** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 132 (estimated)

## Conditions studied

- Depressive Symptoms
- Impaired Cognition
- Electroconvulsive Therapy

## Interventions

- **DRUG:** ketamine and propofol
- **DRUG:** propofol and normal saline

## Key facts

- **NCT ID:** NCT02305394
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305394, "Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02305394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*